{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:01:47Z","timestamp":1790532107939,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jaci.2021.11.027","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T11:16:38Z","timestamp":1640862998000},"page":"1992-1997.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A genomic approach identifies sRAGE as a putatively causal protein for asthma"],"prefix":"10.1016","volume":"149","author":[{"given":"Helena","family":"Bui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amena","family":"Keshawarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Jen","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gha Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Recto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1843-8724","authenticated-orcid":false,"given":"Daniel","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.11.027_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"issue":"484","key":"10.1016\/j.jaci.2021.11.027_bib3","article-title":"Targeting inflammation driven by HMGB1","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.11.027_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/157016110790226642","article-title":"Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation","volume":"8","author":"Lanati","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jaci.2021.11.027_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE signaling in inflammatory disease","volume":"69","author":"Hudson","year":"2018","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2021.11.027_bib6","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3899\/jrheum.110058","article-title":"Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels","volume":"38","author":"Myles","year":"2011","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jaci.2021.11.027_bib7","article-title":"Serum level of soluble receptor for advanced glycation end products in asthmatic children and its correlation to severity and pulmonary functions","volume":"60","author":"El-Seify","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.jaci.2021.11.027_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003774","article-title":"A systemic inflammatory endotype of asthma with more severe disease identified by unbiased clustering of the serum cytokine profile","volume":"95","author":"Liang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2021.11.027_bib9","first-page":"33","article-title":"Fraction of exhaled nitric oxide and soluble receptors for advanced glycation end products are negatively correlated in children with recurrent wheezing","volume":"35","author":"Li","year":"2017","journal-title":"Asian Pacific J Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.11.027_bib10","first-page":"4131","article-title":"Decreased soluble RAGE in neutrophilic asthma is correlated with disease severity and RAGE G82S variants","volume":"17","author":"Lyu","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jaci.2021.11.027_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1183\/09031936.00022011","article-title":"Soluble RAGE is deficient in neutrophilic asthma and COPD","volume":"39","author":"Sukkar","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.11.027_bib12","first-page":"1","article-title":"sRAGE alleviates neutrophilic asthma by blocking HMGB1\/RAGE signalling in airway dendritic cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2021.11.027_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008108","article-title":"Protein biomarkers of cardiovascular disease and mortality in the community","volume":"7","author":"Ho","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaci.2021.11.027_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general US population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2021.11.027_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaci.2011.09.029","article-title":"A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study","volume":"129","author":"Granada","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.027_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jaci.2021.11.027_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/gepi.22284","article-title":"Power calculation for the general two-sample Mendelian randomization analysis","volume":"44","author":"Deng","year":"2020","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.jaci.2021.11.027_bib18","article-title":"Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease","volume":"9","author":"Yao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2021.11.027_bib19","doi-asserted-by":"crossref","unstructured":"Elsworth B, Lyon M, Alexander T, Liu Y, Matthews P, Hallett J, et\u00a0al. The MRC IEU OpenGWAS data infrastructure. bioRxiv 2020;2020.08.10.244293. Available at: https:\/\/doi.org\/10.1101\/2020.08.10.244293.","DOI":"10.1101\/2020.08.10.244293"},{"key":"10.1016\/j.jaci.2021.11.027_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jaci.2021.11.027_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2021.11.027_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.jaci.2021.11.027_bib23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2021.11.027_bib24","series-title":"R: a language and environment for statistical computing","year":"2020"},{"key":"10.1016\/j.jaci.2021.11.027_bib25","doi-asserted-by":"crossref","unstructured":"Cano-Gamez E, Trynka G. From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases. Vol. 11, Frontiers in Genetics 2020.","DOI":"10.3389\/fgene.2020.00424"},{"key":"10.1016\/j.jaci.2021.11.027_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaci.2021.11.027_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jaci.2019.03.019","article-title":"The receptor for advanced glycation end products is a critical mediator of type 2 cytokine signaling in the lungs","volume":"144","author":"Perkins","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.027_bib28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2015.03.011","article-title":"Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells","volume":"136","author":"Oczypok","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.027_bib29","article-title":"sRAGE inhibits the mucus hypersecretion in a mouse model with neutrophilic asthma","author":"Zhang","year":"2021","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jaci.2021.11.027_bib30","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/pai.13478","article-title":"Soluble receptor for advanced glycation end products (sRAGE) and asthma: Mendelian randomisation study","author":"Raita","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.11.027_bib31","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s10620-015-3619-7","article-title":"The circulating level of soluble receptor for advanced glycation end products displays different patterns in ulcerative colitis and Crohn\u2019s disease: a cross-sectional study","volume":"60","author":"Ciccocioppo","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2021.11.027_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000357002","article-title":"Decreased level of sRAGE in the cerebrospinal fluid of multiple sclerosis patients at clinical onset","volume":"21","author":"Glasnovi\u0107","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jaci.2021.11.027_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci11081021","article-title":"The assessment of serum concentrations of ages and their soluble receptor (Srage) in multiple sclerosis patients","volume":"11","author":"Damasiewicz-Bodzek","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.jaci.2021.11.027_bib34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40618-020-01231-7","article-title":"Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto\u2019s thyroiditis","volume":"43","author":"Ruggeri","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jaci.2021.11.027_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2067353","article-title":"Pathological implications of receptor for advanced glycation end-product (AGER) gene polymorphism","volume":"2019","author":"Serveaux-Dancer","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.jaci.2021.11.027_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164041","article-title":"The Ser82 RAGE variant affects lung function and serum RAGE in smokers and sRAGE production in vitro","volume":"11","author":"Miller","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2021.11.027_bib37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.201302-0247OC","article-title":"Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease","volume":"188","author":"Cheng","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2021.11.027_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/resp.12995","article-title":"AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis","volume":"22","author":"Yamaguchi","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2021.11.027_bib39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.humimm.2004.01.005","article-title":"Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men","volume":"65","author":"Holling","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2021.11.027_bib40","series-title":"Causality Assessment of HLA region associations in GWAS for autoimmune diseases","author":"Dorak Tevflik","year":"2015"},{"key":"10.1016\/j.jaci.2021.11.027_bib41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1183\/09031936.06.00048605","article-title":"Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma","volume":"27","author":"Horvath","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.11.027_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3346\/jkms.2017.32.3.439","article-title":"Relationship between fractional exhaled nitric oxide level and efficacy of inhaled corticosteroid in asthma-COPD overlap syndrome patients with different disease severity","volume":"32","author":"Feng","year":"2017","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jaci.2021.11.027_bib43","article-title":"Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial","volume":"6","author":"Celli","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jaci.2021.11.027_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1034\/j.1399-3003.2000.16d07.x","article-title":"Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals","volume":"16","author":"Beeh","year":"2000","journal-title":"Eur Respir J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921027469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921027469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:39:04Z","timestamp":1758793144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921027469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0091674921027469"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.027","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A genomic approach identifies sRAGE as a putatively causal protein for asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}